Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W D Heston

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
Clinical Chemistry|December 1, 1995
Detection of hematogenous dissemination of prostatic cancer by RT-PCR with primers specific for prostate-specific membrane antigenW D Heston
Der Urologe. Ausg. A|September 1, 1996
[Significance of prostate-specific membrane antigen (PSMA). A neurocarboxypeptidase and membrane folate hydrolase]W D Heston
Urology|March 1, 1997
Characterization and glutamyl preferring carboxypeptidase function of prostate specific membrane antigen: a novel folate hydrolaseW D Heston
Cancer Surveys|January 1, 1991
Prostatic polyamines and polyamine targeting as a new approach to therapy of prostatic cancerW D Heston
The Journal of Urology|October 1, 1986
alpha-Difluoromethylornithine enhancement of 14C-putrescine uptake by an androgen-dependent prostatic tumorW D Heston, D Kadmon
Biochemical Pharmacology|July 1, 1988
Calmodulin antagonist inhibition of polyamine transport in prostatic cancer cells in vitroW D Heston, M Charles
Progress in Clinical and Biological Research|January 1, 1977
The relationship of bacterial prostatitis and zincW R Fair, W D Heston
Cancer Letters|November 1, 1980
High dose estrogen response of the hormone independent R3327-At Copenhagen rat prostatic tumorW D Heston, D W Lazan
Cancer Treatment and Research|January 1, 1992
Suramin as an archetypical compound in the development of growth factor antagonists for inhibition of genitourinary tumorsH I Scher, W D Heston
The Urologic Clinics of North America|August 1, 1991
Is combined modality therapy appropriate for apparently localized carcinoma of the prostate?W R Fair, W D Heston
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Clinical Chemistry|December 1, 1995
Detection of hematogenous dissemination of prostatic cancer by RT-PCR with primers specific for prostate-specific membrane antigenW D Heston
Der Urologe. Ausg. A|September 1, 1996
[Significance of prostate-specific membrane antigen (PSMA). A neurocarboxypeptidase and membrane folate hydrolase]W D Heston
Urology|March 1, 1997
Characterization and glutamyl preferring carboxypeptidase function of prostate specific membrane antigen: a novel folate hydrolaseW D Heston
Cancer Surveys|January 1, 1991
Prostatic polyamines and polyamine targeting as a new approach to therapy of prostatic cancerW D Heston
The Journal of Urology|October 1, 1986
alpha-Difluoromethylornithine enhancement of 14C-putrescine uptake by an androgen-dependent prostatic tumorW D Heston, D Kadmon
Biochemical Pharmacology|July 1, 1988
Calmodulin antagonist inhibition of polyamine transport in prostatic cancer cells in vitroW D Heston, M Charles
Progress in Clinical and Biological Research|January 1, 1977
The relationship of bacterial prostatitis and zincW R Fair, W D Heston
Cancer Letters|November 1, 1980
High dose estrogen response of the hormone independent R3327-At Copenhagen rat prostatic tumorW D Heston, D W Lazan
Cancer Treatment and Research|January 1, 1992
Suramin as an archetypical compound in the development of growth factor antagonists for inhibition of genitourinary tumorsH I Scher, W D Heston
The Urologic Clinics of North America|August 1, 1991
Is combined modality therapy appropriate for apparently localized carcinoma of the prostate?W R Fair, W D Heston
Pageof 12